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The substrate specificity of purified PKC-a, -/I and -y has been investigated. A series of synthetic peptides based upon the sequence surrounding 
serine-7 in giycogen synthase were generated and used to determine the basic residue requirements of these PKC isotypes. While PKC-a and -b 
are indistinguishable in their phospho~lation of these peptides, PKC-y shows a distinct specificity profile for these synthetic substrates. 
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1. INTRODUCTION 
Protein kinace C (PKC) is a ubiquitous serine- and 
threonine-specific protein kinase which occupies a 
pivotal role in signal transduction (for recent reviews 
see [l-3]). PKC is distinguished from other kinases in 
that it is dependent on phospholipids, Ca2+ and 
diacylglycerol (DG) for activation. PKC is the major 
celfular receptor for the tumour promoting phorbol 
esters [4] and has therefore been implicated in 
neoplastic transformation of cells. The cloning of PKC 
has revealed that this kinase exists as a family of at least 
7 closely related proteins [1,3]. Within this family, 
PKC-(r, $1, $32 and -y are more closely related to each 
other than they are to PKC-S, -E and I. PKC-a, -&r + 2) 
and -y mixtures have been purified from numerous 
sources. The purified PKC-cz, -&i + 2) and -y isotypes 
have been separated from each other by hydrox- 
ylapatite column chromatography and this has allowed 
biochemical analysis of the individual isotypes 15-91. 
These isotypes all fall into the broad class of 
Ca2 * /phospholipd- and DG-dependent kinases and are 
all activated by phorbol esters. Studies have revealed 
also that there are subtle differences in their activation 
kinetics which may be indicative of different 
physiological roles for each isotype (see for example 
15,781). 
Most comparative studies on purified PKC isotypes 
have employed polypeptide substrates (see for example 
[5-g]). However, for a more detailed analysis of 
substrate requirements it is desirable to employ syn- 
thetic peptides that can be manipulated readily. Studies 
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along these lines have been carried out for undefined 
mixtures of PKC but not for separated isotypes [l&14]. 
We report here on an analysis of the substrate re- 
quirements of the PKC-a, -Pi and -y isotypes using syn- 
thetic peptide substrates. 
2. MATERIALS AND METHODS 
Chemical and biochemical reagents were as described previously [S] 
except where indicated below. PKC-(w, -PI and -y were isolated from 
bovine brain and separated by hydroxylapatite chromatography as 
previously described; the isotypes were judged pure when analysed by 
SDS-PAGE and immunoblot analysis using isotype-specific antisera 
]81. 
Assays of PKC isotypes were as described previously [S] except us- 
ing the various substrates indicated in the text, tables and figures. 
Reactions were terminated by one of two methods; either (i) to 20 pi 
of reaction mixture, 20 pl of Laemmli sample buffer 1151 was added 
and the phosphopeptides were separated from free ATP on 25% 
polyacrylamide gels; following autoradiography, the amount of 
[“Plphosphate incorporated into peptide was determined by 
Cerenkov counting; or (ii) samples (25 ,aI) were spotted onto P81 
paper and washed in 30% (v/v) acetic acid for 2 x 10 min; incor- 
porated [32P]phosphate was determined by Cerenkov counting. One 
set of analyses with all synthetic peptide substrates was carried out by 
SDS-PAGE (method i) and the results were entirely consistent with 
data employing the PSI procedure (method ii). The latter was subse- 
quently used for all further studies except for those with peptides con- 
taming only one basic residue, such as peptide R6Sg (see below) which 
did not bind to P81 efficiently. A unit of enzyme activity is defined 
as the amount incorporating 1 pmol of phosphate into the 
substrate/min at 30°C under the conditions described. 
Peptides GSI-10 EGFR-1, MBP-I and pp60src- ’ were as described 
previously [IO]. GSI-lo-related peptides were synthesised on an 
automated Applied Biosystems 430A peptide synthesiser according to 
the manufacturer’s instructions. The peptides were purified by reverse 
phase HPLC, using a Crs column equiiibrat~ in 0.1% TFA and at- 
tached to a Beckman Gold System; peptides were eluted using a linear 
gradient from 0% to 60% acetonitrile (Rathburn). Purified peptides 
were lyophilised, resuspended in 0.2 M Hepes, pH 7.5, 2 mM EGTA 
and used directly. In order to reduce cost during synthesis, the pep- 
tides with identica1 C-termini were synthesised in a single batch, from 
residues 13-8. The beads were then split 4 ways and each peptide fur- 
ther extended individuaIly. Peptide nomenclature is as follows: in 
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each case the position of the basic arginine residue and the 
phosphorylated serine residue is given, e.g. NHz-GGRLARALS- 
VAAG-COOH is abbreviated to R3R6S9. 
Kinetic analysis of data was carried out using the Enzfitter program 
(Elsevier Biosoft). In the case of peptides with arginine residues at 
positions 11 and 12 substrate inhibition was observed for PKC-o; 
therefore for these peptides optimal activity and the concentrations 
giving half-maximal activity (S0.s) are described in place of V,,,,, and 
Km values, respectively (these values were determined graphically). 
3. RESULTS AND DISCUSSION 
3.1. Synthetic peptides corresponding to known PKC 
substrates 
Peptides corresponding to the major PKC 
phosphorylation sites in the epidermal growth factor 
receptor, pp60’-““, myelin basic protein and glycogen 
synthetase have all been shown to be substrates for 
undefined mixtures of PKC [lo]. These peptides were 
therefore used to analyse the substrate specificity of the 
PKC isotypes and were all found to be phosphorylated 
by PKC-(r, -0, and -y (Table I). For PKC-CY, the range 
of apparent K, values with these peptide substrates 
varied from 15 PM to 220 ,uM. Although these values 
differ from published data (Table I), the discrepancies 
probably reflect different assay conditions and varia- 
tions in PKC isotype content. The V,,, values with 
these peptides varied from 0.56 to 2.2 pmol/min/mg 
for PKC-CX. PKC-fir displayed similar kinetics to PKC- 
(Y for these peptides, the apparent K,,, values being 
within two-fold of the values for PKC-(r; however, the 
V,,, values for PKC-/3i were consistently 2-4-fold 
lower than the values for PKC-CY. The reduced activity 
of PKC-/3i compared to PKC-ol has been noted 
previously for polypeptide substrates [5-81. 
In contrast to PKC$i, PKC--y displayed a significant 
difference in substrate specificity compared to PKC-a. 
The apparent K, values of PKC-7 were within 2.5-fold 
of the values for PKC-CY for peptides EGF-R3, ~60-1 
and MBP-1, but for GSl-10, the difference was greater 
than lo-fold. The V,,, values of PKC--y were approx- 
imately 2-fold lower than the values of PKC-cx even for 
GSl-10. While the differences in V,,, values are consis- 
tent with observations made for protein substrates, no 
substrate has been described previously in which there is 
such a large difference in Km between the isotypes [5-81. 
3.2. Derivatives of the GSI-IO peptide 
PKC mixtures have been shown to phosphorylate 
serine or threonine residues flanked by basic amino 
acids [lo-141. Peptide GSl-10 contains only a single 
basic residue (R4) in addition to the N-terminus and 
therefore does not conform to the PKC substrate ‘con- 
sensus’. Nevertheless, this peptide is a substrate for 
PKC and is phosphorylated exclusively on serine 
residue 7 by PKC [ll]; R.M.M., Ph.D. thesis). In order 
to investigate the basis of the differential substrate 
characteristics of the PKC isotypes with this peptide, 
the effect of the number and position of the basic 
residues on this peptide were altered. Peptides based on 
the GSl-10 sequence were synthesised, with S3 and T5 
being replaced by alanine residues to avoid the possibili- 
ty of secondary phosphorylation events which would 
complicate the analysis. The N- and C-termini of this 
family of peptides were also extended by additional 
residues to accommodate basic residues at these posi- 
tions so that their influence on substrate specificity 
could be evaluated. 
In initial studies, PKC-a! and $1 were found to 
display indistinguishable characteristics towards these 
peptides (data not shown) and therefore for clarity we 
have detailed here the PKC-a and PKC--r data (Table 
II). 
3.3. PKC-ar requirements for substrate specificity 
PKC-a! showed an apparent K, value for peptide 
GSl-10 of 53 PM and a I/max of 2.2 units/mg. The pep- 
tide which most closely resembles GSl-10 with respect 
to the positioning of basic residues is peptide R3R6S9. In 
this peptide, R6 occupies the position corresponding to 
R4 in GSl-10 and R3 the position corresponding to the 
GSl-10 N-terminus (which is predicted to be positively 
charged). However, R3R6S9 is a less efficient PKC-(Y 
substrate than GSl-10, with a lower I’,,, and a higher 
Table 1 
Phosphorylation of physiological substrate peptides by PKC-ol, $31 and -y 
EGF-R3 ~60-1 MBP-1 GSl-10 
K, V max K, V Inax K, V max K, V max 
PKC-ol 15 +2.9 0.56 + 0.06 220+21 1.5 k9.1 82+ 7.4 0.89 + 0.04 53* 10 2.2 f0.09 
PKC-01 7.6* 1.7 0.22 + 0.05 280+ 56 0.87rt_O.10 69-+ 7.8 0.21*0.01 44+ 5.3 0.98+0.02 
PKC-y 15 k3.3 0.23 f 0.03 260+ 16 0.75 f0.02 1462 14 0.37 + 0.06 550* 110 1.2 +0.10 
Previous* 48’ 0.990 48’ 0.560 222 0.213 4o.33 1.60 
The apparent K, and V,,,,, values for the three PKC isotypes are indicated. The Km units are FM and the V,,, values expressed as gmol/min/mg. 
The assays with these peptides were performed in standard assay buffer (lacking histone; total volume = 20 ~1) and the reaction were terminated 
(after 3 min, 30°C) by the addition of Laemmli sample buffer as described in section 2. EGF-R3: VRKTLRRLNH,; ~60-1 
GSSKSKPKDPSQRRSLENH,; MBP-I GAGRGLSLSRFSWGA; GSl-10 PLSRTLSVAA (underlined residues are the major target sites). 
*The previously published values for PKC mixtures come from: ‘[lo], ‘[131, ‘[ill 
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apparent K,,, (Table II). Thus the changes which were 
made in converting GSl-10 to R3R6S9 affect both the 
apparent affinity of this peptide for PKC-a! and the tur- 
nover rate. This suggests that it is not only the basic 
residues which are involved in substrate recognition by 
PKC-LY but that other residues can also contribute. 
Nevertheless, R3R6S9 is a substrate for PKC-(r and is 
therefore a useful model peptide on which to base a 
study which examines how the positioning of basic 
residues with respect to the target residue affects PKC 
isotype substrate recognition. Removal of the R residue 
at position 3 results in peptide R6S9 which has almost 
identical kinetics as a PKC-a substrate as R3R6S9. This 
suggests that R3 does not have a major role in the ability 
of PKC-a to recognise peptide R3R6S9. However, R6 is 
important for PKC-(U substrate interaction, since for 
example peptide R5S9 is not a PKC-a substrate (the syn- 
thetic peptide lacking any R residues was insoluble in 
aqueous buffers and therefore could not be tested). 
Inclusion of a second basic amino acid proximal to 
R6 does not significantly affect the kinetic parameters 
of the peptide for PKC-a as seen in peptides R5R6S9 and 
R6R7S9. Thus the presence of an R residue at position 6 
appears to be the most important N-terminal residue 
for PKC-a substrate recognition; the presence of a se- 
cond basic residue at only one of the positions 3, 5 or 7 
having a minimal effect on substrate recognition. 
However, positions 3 and 5 together have a synergistic 
effect on substrate recognition, since peptide R3RSR6S9 
has a Vmax 3.3-fold higher and an apparent K,,, value 
4-fold lower than R6S9. From this we conclude that in 
the presence of an R residue at position 6, basic residues 
at either position 3 or 5 alone do not have a significant 
effect on substrate recognition by PKC-(r; however, 
when both positions 3 and 5 are occupied by R residues, 
there is a significant co-operative contribution to 
substrate recognition. Similarly the combination of R3 
and R’ with R6 produces a substrate with lower ap- 
parent K, and higher V,,,,, (not shown). 
C-terminal residues also influence the recognition of 
substrates by PKC-a. Thus, peptide R6S9R12 has a 
2.9-fold higher V,,, and a 2.3-fold lower apparent K,,, 
than R6S9. This effect of R12 on peptide recognition is 
further enhanced for those peptides with more than one 
basic residue N-terminal to the target site. Thus 
R6R7S9R12, R5R6S9R12 and R3R6S9R1’ have significant- 
ly higher V,,, values and very much lower apparent K, 
values than the corresponding peptides lacking R12. As 
mentioned above, peptides containing only two N- 
terminal basic amino acids were marginally better 
substrates than peptides with one N-terminal basic 
residue (see above). By contrast, peptides with two N- 
terminal basic residues in the presence of RI2 have ap- 
parent Km values of the order of lo-50-fold lower than 
peptides with only a single N-terminal basic residue. It 
therefore appears that the C-terminal basic residue is 
able to synergise with multiple N-terminal basic 
residues more efficiently than with single N-terminal 
basic residues. There is nonetheless a requirement for 
N-terminal basic residues since the peptide S9R1’ is not 
phosphorylated by PKC-a indicating that a basic 
residue at position 12 is not sufficient on its own to 
direct PKC-a substrate recognition. 
Increasing the number of basic residues C-terminal to 
the target had unusual effects on PKC-(Y substrate 
kinetics for this series of peptides. Peptides containing 
Table II 
PKC-cu and -7 activities towards synthetic peptide substrates 
PKC-ol PKC-7 
Peptide K, V max K, V mar 
RY 180 f 43 0.13 kO.01 N/S 
R6R7S9 350 *250 0.32 + 0.01 N/S 
Rs R6S9 330 k 69 0.23 + 0.03 N/S 
R’R?? 190 f 2.0 0.13 kO.00 N/S 
R3RsRbS9 46 f 2.6 0.44 + 0.01 170 +24 0.19+0.02 
R6S9R” 80 _t 19 0.40 * 0.02 170 *12 0.26 + 0.01 
R6R7S9R’= 7.9* 0.9 0.69 zk 0.02 16 +_ 5.0 0.50 * 0.05 
R5R6S9R’= 12 + 1.6 0.55 + 0.02 38 k 8.0 0.51 kO.04 
R3R6S9R” 19 + 4.0 0.52 + 0.03 110 *11 0.42kO.02 
~6.39~11~12 7.6+ 2.2* 0.57+0.11* 20 kl7 0.34t0.01 
~6~7~9~11~12 3.lk 1.6* 0.59 + 0.02* 3.6k 0.5 0.31 kO.01 
RSR6S9R”R12 2.5 + 0.8* 0.43 + 0.05* 5.4t0.9 0.32+0.02 
Peptides were employed as substrates for PKC-or and PKC-y as described in section 2. Values shown are means and SD for one of three similar 
determinants. Apparent Km values are in cM units and V,,,,, values are expressed as pmol/min/mg. N/S, not saturating; low activity is observed 
with PKC--/ as shown in Fig. 1 for R6S9. 
*Due to substrate inhibition (see Fig. 2) these values are not K,,, and V max values but substrate concentrations giving half-optimum activity (PM) 
and optimum activity values (pmol/min/mg) 
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basic residues at positions 11 and 12 were all 
phosphorylated by PKC-a with So.5 values between 2 
and 8 PM, but in all cases the PKC-a activity was in- 
hibited at high peptide concentrations (see for example 
Fig. 2). It was therefore not possible to obtain V,,,,, 
values for these peptide substrates, and optimum activi- 
ty values are shown in Table II. The inhibition observed 
would not appear to be non-specific since: (i) following 
synthesis, deprotection and precipitation, the peptides 
were all repurified by HPLC (as described in section 2); 
and (ii) no substrate inhibition is observed with PKC-7 
(see below). The reason for this inhibition of PKC-a! 
(and PKC-0; data not shown) is not clear. 
3.4. PKC-y substrate specificity 
PKC-y displayed very low rates of phosphorylation 
with peptides R6Sg, R6R7Sg, RSR6S9 or R3R6S9 and it 
was not possible to saturate the activity (Table II and 
see Fig. 1). However, PKC-7 was able to phosphorylate 
the peptide R3RSR6S9, indicating that in this model 
system PKC-7 can recognise substrates with three basic 
residues N-terminal to the target site in the absence of 
C-terminal basic residues (see below). 
PKC-7 was able to phosphorylate peptides with both 
C- and N-terminal basic residues. Peptide R6S9R1’ was 
phosphorylated by PKC-7 with similar kinetics (the 
V,,, is slightly higher) to R3R5R6S9, indicating that in 
the presence of a C-terminal basic residue, the require- 
ment of PKC-7 for multiple N-terminal basic residues is 
in part relieved. However, N-terminal basic residues are 
still required (in the presence of a single C-terminal 
basic residue) since peptide S9R12 is not a PKC--y 
substrate; in contrast, the peptide S9R”R” is a 
substrate for PKC-7 albeit with a high apparent K,,, and 
a low I/max (data not shown). 
Peptide R6R7S9R12 is an excellent PKC--y substrate, 
with an apparent Km 10.7-fold lower and a V,,, 2-fold 
higher than R6SgR1’. Evidently the inclusion of an addi- 
tional basic residue to peptide R6S9R12 creates a good 
PKC-7 substrate. The precise location of the pair of N- 
terminal basic residues has a significant influence on 
K,. This can be seen by comparing peptides R6R7SgR”, 
R5R6S9R12, and R3R6SgR1’; the apparent Km values for 
PKC-7 of R5R6SgR12 and R3R6SgR12 are 2.4- and 7-fold 
higher than R6R7SgR12, respectively, although the I’,,,,, 
values of these peptides are similar (Table I). In- 
terestingly the peptide R5SgR12 was not a good PKC-7 
substrate and behaved as the R6S9 (see Fig. 1). Thus 
PKC-7 is sensitive to the precise positioning of basic 
residues urrounding the target site in substrate recogni- 
tion. 
Inclusion of a second C-terminal basic residue fur- 
ther improves the efficiency with which PKC-r is able 
to phosphorylate these peptides (Table II). Unlike 
PKCG, substrate inhibition is not observed for PKC--y 
with these peptides (see Fig. 2). Thus peptide 
R6S9R”R12 has an 8.6-fold lower apparent K, and 
similar I/max to R6S9R12 (Table II). Inclusion of more 
than one N-terminal basic residue further increases the 
apparent affinity o this class of peptides for PKC-7, 
with peptides R6R7SgR11R12 and R5R6SgR11R12 having 
5.6- and 3.7-fold lower K,,, values, respectively, than 
0.0 
yAyy---y, . I . , . ( . , 
0 100 200 300 400 500 600 
R6S9 Concentration (uM) RhS9R 11 R 12 Concenaation (uM) 
Fig. 1. A comparison of PKC-(Y and PKC--, activity with the peptide 
substrate R6S9. Peptide R’S9 was assayed with purified PKC-cx (*-•) 
and PKC-y (O-o) as described in section 2. Data points are means of 
duplicate observations from a single set of analyses and are 
Fig. 2. A comparison of PKC-CI and PKC-7 activity with the peptide 
substrate R%?R”R”. Peptide R6S9R”R’2 was assayed with purified 
PKC-cx (g-0) and PKC-7 (o-o) as described in section 2. Data points 
are means of duplicate observations; this is one of three sets of 
analyses with this substrate. Similar substrate inhibition of PKC-ol is 
representative of 3 separate analyses. seen with peptides R6R7S9R”R’* and RSR6S9R”R’*. 
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R6S9R’1R’Z (Table II). The Km of R6R7S9R11R12 is the 
lowest for this class of peptides for PKC-7 and once 
again shows how the position of N-terminal basic 
residues affects the interaction of PKCy with these 
peptide substrates. 
4. CONCLUSIONS 
The different kinetics with which PKC-7 
phosphorylates the GSl-10 peptide compared to PKC-(r 
or -p has provided a model in which to investigate and 
compare the substrate specificity of these PKC isotypes. 
Based upon the GSl-10 sequence a series of substrate 
peptides have been synthesised that reveal differences in 
the primary structural determinants for these isotypes. 
Both PKC-c~ and -/3 isotypes display a preference for a 
basic residue at position 6 relative to the target serine at 
9 and substantially lower apparent K,,, values when a 
single basic residue C-terminal to the target serine is in- 
cluded at position 12. It can be concluded that within 
the context of the parent peptide, PKC-cx and -/3 display 
the same basic residue requirements. By contrast, PKC- 
y showed a distinct pattern of specificity, showing selec- 
tivity for peptide substrates that retain a basic residue 
C-terminal to the phosphorylated serine. In the absence 
of a C-terminal basic residue PKC--r phosphorylation 
could not be saturated within the limits of peptide 
solubility unless multiple N-terminal basic residues were 
also present. However, as exemplified in Fig. 1, PKC-7 
was able to phosphorylate these peptides albeit at a low 
rate. It is therefore possible that the Vmax values of 
PKC-7 for these peptides may not differ substantially 
from those determined for PKC-CY (or PKC-/3) but that 
the apparent Km values are significantly different. This 
is consistent with the ‘parent’ peptide GSI-10 which 
showed a lo-fold higher K,,, value for PKC-y relative to 
-cy or -/3. 
It is anticipated that these differences in primary 
structural determinants for synthetic substrates for 
PKC-a, -P and -y relate to the selective roles played by 
these kinases in vivo. Further studies with physiological 
substrates will no doubt define the consequences of this 
specificity. 
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